Perrigo Company plc $PRGO Shares Purchased by VIRGINIA RETIREMENT SYSTEMS ET Al

VIRGINIA RETIREMENT SYSTEMS ET Al raised its stake in shares of Perrigo Company plc (NYSE:PRGO) by 275.1% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 79,900 shares of the company’s stock after acquiring an additional 58,600 shares during the period. VIRGINIA RETIREMENT SYSTEMS ET Al owned approximately 0.06% of Perrigo worth $1,179,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in the stock. KBC Group NV grew its position in Perrigo by 61.3% during the first quarter. KBC Group NV now owns 6,283 shares of the company’s stock worth $67,000 after buying an additional 2,388 shares during the period. Parvin Asset Management LLC acquired a new position in Perrigo during the second quarter worth $79,000. Allworth Financial LP raised its holdings in Perrigo by 489.1% during the second quarter. Allworth Financial LP now owns 9,390 shares of the company’s stock worth $98,000 after purchasing an additional 7,796 shares during the last quarter. Signaturefd LLC boosted its position in Perrigo by 20.4% during the third quarter. Signaturefd LLC now owns 10,184 shares of the company’s stock worth $150,000 after purchasing an additional 1,726 shares in the last quarter. Finally, Whitebox Advisors LLC purchased a new stake in Perrigo during the first quarter worth $111,000. 95.91% of the stock is owned by institutional investors and hedge funds.

Trending Headlines about Perrigo

Here are the key news stories impacting Perrigo this week:

• Positive Sentiment: Perrigo posted adjusted EPS of $0.60, ahead of the $0.51 consensus estimate. Management also reported sequential operating improvement under its Three-S plan, with market-share gains in U.S. store-brand OTC products and key European brands. Perrigo Q3 2026 results
• Neutral Sentiment: The planned infant formula divestiture is intended to simplify Perrigo’s portfolio and focus investment on higher-return consumer self-care categories. A strategic review of the Oral Care business is still ongoing, leaving the outcome uncertain. Perrigo Q3 2026 results
• Negative Sentiment: Revenue of $988.6 million slightly exceeded estimates but fell 5.2% from a year earlier; adjusted EPS also declined from $0.80 a year ago. Perrigo reported a net loss for the quarter. Its updated 2026 outlook reflects more cautious retailer inventory positioning and continued softness in Europe, which could weigh on results. Perrigo slips to loss in Q3 Perrigo Q3 2026 results

Perrigo Stock Performance

Perrigo stock opened at $15.84 on Thursday. Perrigo Company plc has a 12-month low of $9.23 and a 12-month high of $17.48. The company has a debt-to-equity ratio of 1.31, a current ratio of 2.32 and a quick ratio of 1.32. The company has a market capitalization of $2.20 billion, a price-to-earnings ratio of -1.27, a price-to-earnings-growth ratio of 1.81 and a beta of 0.71. The firm’s fifty day moving average price is $14.91 and its 200 day moving average price is $12.49.

Perrigo (NYSE:PRGO) last posted its quarterly earnings data on Wednesday, November 4th. The company reported $0.60 earnings per share for the quarter, beating analysts’ consensus estimates of $0.51 by $0.09. The company had revenue of $988.60 million during the quarter, compared to analysts’ expectations of $984.80 million. Perrigo had a negative net margin of 41.85% and a positive return on equity of 11.25%. The firm’s revenue for the quarter was down 5.2% on a year-over-year basis. During the same period in the prior year, the company posted $0.80 EPS. On average, research analysts forecast that Perrigo Company plc will post 2.17 EPS for the current fiscal year.

Perrigo Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 15th. Shareholders of record on Friday, November 27th will be given a dividend of $0.29 per share. This represents a $1.16 dividend on an annualized basis and a dividend yield of 7.3%. The ex-dividend date is Friday, November 27th. Perrigo’s payout ratio is -9.27%.

Analysts Set New Price Targets

Several analysts have issued reports on the stock. Zacks Research downgraded shares of Perrigo from a “hold” rating to a “strong sell” rating in a report on Thursday, October 29th. Canaccord Genuity Group lifted their price objective on Perrigo from $17.00 to $19.00 and gave the stock a “buy” rating in a research report on Friday, October 30th. Wall Street Zen lowered Perrigo from a “buy” rating to a “hold” rating in a research note on Saturday, October 31st. Finally, Weiss Ratings upgraded Perrigo from a “sell (d-)” rating to a “sell (d)” rating in a report on Thursday, August 6th. One equities research analyst has rated the stock with a Buy rating, three have given a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Reduce” and a consensus target price of $18.50.

About Perrigo

Perrigo Company plc is a global consumer self-care company that develops, manufactures and markets over-the-counter health products, wellness products and personal care items. Its portfolio includes products for allergy, pain relief, digestive health, skin care, smoking cessation, women’s health and other everyday health needs, along with vitamins, nutritional supplements and infant nutrition products.

Perrigo supplies products under its own brands, acquired brands and retailer-owned private-label labels.